“www닷 yeotop4 。 COM 》 애오개오피✧애오개키스방➙애오개건마✸애오개OPご애오개오피Ⅱ애오개풀싸롱ょ애오개안마”的搜索结果，显示 421-430 项，共有 11103 项

1. 神经科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to collect blood samples for DNA analysis from patients clinically diagnosed with Alzheimers disease, Lewy Body ...

2. 外科 - 临床试验- 妙佑医疗国际

   The purpose of this study is to to bring molecular risk prediction for breast cancer into the clinical arena through: the establishment of a large tissue ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... 2-year progression free survival (PFS) rate as compared to ACNS0122. ... [1, 2] The solid tumor ... 》2024-2025 全美最佳癌症医院评选中名列前茅。 了解 ...

4. 神经科- 临床试验- 妙佑医疗国际

   The objectives of this study are to determine the Maximum Tolerated Dose (MTD) and the Recommended Phase 2 Dose (RP2D) of NMS-03305293 in combination with ...

5. 神经科- 临床试验- 妙佑医疗国际

   The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...

6. 神经科- 临床试验- 妙佑医疗国际

   The purpose of this study is to measure target engagement in cerebrospinal fluid (CSF) and blood, and to establish the feasibility and safety of Dasatinib ...

7. 神经科- 临床试验- 妙佑医疗国际

   The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...

8. 妙佑医疗国际 - 识别和治疗百日咳

   观看妙佑医疗国际的这段YouTube 视频，讲述了一名21 个月大的男孩所表现出的百日咳体征，以及对医学博士Thomas Boyce 的采访。

9. 神经科- 临床试验- 妙佑医疗国际

   The purpose of this study is to measure target engagement in cerebrospinal fluid (CSF) and blood, and to establish the feasibility and safety of Dasatinib ...

10. 神经科- 临床试验- 妙佑医疗国际

    The purpose of this study is to determine the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of WSD0922-FU in subjects with recurrent ...